文献速递垂体与肾上腺疾病

多发性内分泌腺瘤病1型垂体腺瘤发生风险因素:240例全国性研究

Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

这项全国性多中心回顾性队列研究纳入240例多发性内分泌腺瘤病1型(MEN1)患者,旨在识别垂体腺瘤(PA)发生的预测因素。研究发现PA风险集中于较年轻年龄并随后下降,既往原发性甲状旁腺功能亢进、非错义MEN1胚系致病变异和女性性别进一步标记高风险特征。

要点

  • MEN1患者PA风险在较年轻年龄集中并随后下降。
  • 既往原发性甲状旁腺功能亢进、非错义MEN1致病变异和女性性别与PA风险独立相关。
  • 建议对高风险者加强早期成年期影像随访,低风险者可延长间隔。

核心结论

  • MEN1患者PA风险在较年轻年龄集中并随后下降,既往原发性甲状旁腺功能亢进、非错义MEN1胚系致病变异和女性性别标记更高风险。

研究设计与样本

  • 全国性多中心回顾性队列研究,纳入240例MEN1患者,55.8%为女性。
  • 主要变量为年龄相关外显率、PA亚型和大小及MEN1胚系致病变异,主要结局为PA发生。
  • 采用Cox回归先分析全队列,再分析无症状驱动偏倚的前瞻性筛查亚组(n=199)。

主要发现

  • 112例(46.6%)患者检出PA,平均年龄36.1±13.9岁,63.3%通过筛查诊断。
  • 泌乳素瘤(49.1%)和微腺瘤(62.5%)占主导。
  • 全队列中与PA发生独立相关的因素:年龄(每增加一年;HR 0.916,95%CI 0.893-0.993;P<.001)、既往原发性甲状旁腺功能亢进(HR 3.090,95%CI 1.943-4.914,P<.001)、非错义MEN1致病变异(HR 1.976,95%CI 1.125-3.468,P=.018)和女性性别(HR 1.706,95%CI 1.082-2.689,P=.022)。
  • 相同因素在筛查亚组中仍显著。

临床怎么用

  • 对MEN1患者,尤其女性、有既往原发性甲状旁腺功能亢进或非错义MEN1致病变异者,可在早期成年期优先加强垂体影像随访。
  • 基线影像正常且无额外风险标记者,可考虑延长随访间隔,但需更大规模多中心研究验证。

局限性

  • 研究为回顾性队列设计,结论需在更大规模多中心研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pituitary adenomas (PAs) are one of the three major lesions in Multiple Endocrine Neoplasia type 1 (MEN1), with a prevalence of 32% to 58%, yet their specific risk factors remain unidentified. This study aimed to identify predictors influencing PA occurrence in MEN1. METHODS: This nationwide, multicenter, retrospective cohort study involved 240 MEN1 patients, 55.8% female. The main variables were age-related penetrance, PA subtype and size, and MEN1 germline pathogenic variants (PVs). The primary outcome was PA development. Cox regression was applied first to the full cohort and then to a prospectively screened subgroup (n = 199) free of symptom-driven bias. RESULTS: PAs were detected in 112 (46.6%) patients at a mean age of 36.1 ± 13.9 years; most (63.3%) were diagnosed through screening. Prolactinomas (49.1%) and microadenomas (62.5%) predominated. In the full cohort, the following independent factors were related to PA development: age (per additional year; HR 0.916, 95% CI 0.893-0.993; P < .001), prior primary hyperparathyroidism (HR: 3.090, 95% CI: 1.943-4.914, P < .001), non-missense MEN1 PVs (HR: 1.976, 95% CI: 1.125-3.468, P = .018), and female sex (HR: 1.706, 95% CI: 1.082-2.689, P = .022). The same factors remained significant in the screened subgroup. CONCLUSION: Risk of PA in MEN1 clusters at younger ages and declines thereafter. Prior primary hyperparathyroidism, non-missense MEN1 PVs, and female sex further mark higher-risk profiles. These findings may help personalize PA follow-up-prioritizing closer imaging in early adulthood and allowing longer intervals when baseline imaging is normal and additional risk markers are absent-pending validation in larger multicenter studies.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Valdés N, Romero-Lluch AR, Diego E, et al. Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases. J Clin Endocrinol Metab. 2026. PMID: 40921719. doi:10.1210/clinem/dgaf497

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。